SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-22-000840
Filing Date
2022-02-10
Accepted
2022-02-10 15:13:57
Documents
15
Period of Report
2022-02-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sunshine_8k.htm   iXBRL 8-K 25526
2 AMENDMENT TO ARTICLES OF INCORPORATION RE-ESTABLISHING CAPITALIZATION FOLLOWING sunshine_ex0307.htm EX-3.7 14408
3 GRAPHIC image_001.jpg GRAPHIC 165242
4 GRAPHIC image_002.jpg GRAPHIC 51353
  Complete submission text file 0001683168-22-000840.txt   514938

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE sbfm-20220209.xsd EX-101.SCH 3060
6 XBRL LABEL FILE sbfm-20220209_lab.xml EX-101.LAB 34476
7 XBRL PRESENTATION FILE sbfm-20220209_pre.xml EX-101.PRE 22613
9 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_8k_htm.xml XML 3622
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41282 | Film No.: 22613485
SIC: 8731 Services-Commercial Physical & Biological Research